The actions of 2 and 5 FATP are dose-dependent and bimodal, and they are mediated by insulin receptor substrate-2 (IRS-2) under low concentrations of insulin and insulin receptor substrate-1 (IRS-1) during states of hyperinsulinemia. The gene discussed is INS; the disease is Hyperinsulinemia.